Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
Wall Street
Price Targets
Price Targets Summary
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
According to Wall Street analysts, the average 1-year price target for Sunshine Guojian Pharmaceutical Shanghai Co Ltd is 26.46 CNY with a low forecast of 26.2 CNY and a high forecast of 27.24 CNY.
Revenue
Forecast
Revenue Estimate
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
For the last 4 years the compound annual growth rate for Sunshine Guojian Pharmaceutical Shanghai Co Ltd's revenue is -8%. The projected CAGR for the next 5 years is 23%.
Net Income
Forecast
Net Income Estimate
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
For the last 4 years the compound annual growth rate for Sunshine Guojian Pharmaceutical Shanghai Co Ltd's net income is -40%. The projected CAGR for the next 4 years is 59%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd's stock price target?
Price Target
26.46
CNY
According to Wall Street analysts, the average 1-year price target for Sunshine Guojian Pharmaceutical Shanghai Co Ltd is 26.46 CNY with a low forecast of 26.2 CNY and a high forecast of 27.24 CNY.
What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd's Revenue forecast?
Projected CAGR
23%
For the last 4 years the compound annual growth rate for Sunshine Guojian Pharmaceutical Shanghai Co Ltd's revenue is -8%. The projected CAGR for the next 5 years is 23%.
What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd's Net Income forecast?
Projected CAGR
59%
For the last 4 years the compound annual growth rate for Sunshine Guojian Pharmaceutical Shanghai Co Ltd's net income is -40%. The projected CAGR for the next 4 years is 59%.